Effect of RCA CTO recanalization on right ventricular function

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026035

Enrollment

100

Registered

2021-08-26

Start date

2019-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I25.1

Interventions

Group 1: Patients undergoing RCA CTO recanalization receive a TTE immediately before coronary angiography and after 6 months. In this TTE, right ventricular function is evaluated by different paramete

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with RCA CTO

Exclusion criteria

Exclusion criteria: under 18 years not able to consent

Design outcomes

Primary

Measure	Time frame
Right ventricular function; assessed by TTE; Measured values of RV function: TAPSE, sTDi, RVEF, RV diamter/area, strain RV and RA.	—

Secondary

Measure	Time frame
Restenosisrate	—

Countries

Germany

Contacts

Public ContactRecha Blessing

Universitätsmedizin MainzZentrum für Kardiologie, Kardiologie I

recha.blessing@unimedizin-mainz.de06131172090

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026